Anish S. Nanavati

Anish Nanavati practices at MedStar Shah Medical Group at Waldorf in Waldorf, Maryland.

Anish Nanavati's NPI, 1154582989, was assigned on June 24, 2008. Anish Nanavati graduated from Northeastern Ohio University College of Medicine in 2008. Anish Nanavati holds Maryland license D0079889.

Anish Nanavati's primary practice is MedStar Shah Medical Group at Waldorf, at 10 St. Patrick'S Drive, Waldorf, MD 20603. The practice phone is (301) 705-7870.

Anish Nanavati's primary practice is MedStar Shah Medical Group at Waldorf in Waldorf, Maryland. Anish Nanavati is also affiliated with MedStar Georgetown University Hospital. The medical group on file is MedStar Shah Medical Group. Dmand AI also links Anish Nanavati to 3 more hospitals and 1 group practice or clinic, each named with a free account. Anish Nanavati's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Anish Nanavati practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Anish Nanavati's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Anish Nanavati is licensed in Maryland.

CMS data shows 85,872 Medicare services from Anish Nanavati across 32 procedure codes in 2024, for 687 Medicare patients. Medicare paid $1,110,963 for them. Every service was in an office.

CMS counts 687 Medicare patients who saw Anish Nanavati in 2024. The largest group is 65 to 74, with 291 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Anish Nanavati's median patient age at 71, with 66% women.

In 2024, Anish Nanavati wrote 899 Medicare Part D claims for 168 patients. 67% of them were for generic drugs. CMS names the drug for 780 of them, across 19 drugs with 11 or more claims each, at $2,005,448 in total drug cost. In 2023, CMS named 493 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Anish Nanavati for performance year 2024, reported as part of a group. Anish Nanavati accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Anish Nanavati as offering telehealth.

CMS Open Payments shows 130 general payments to Anish Nanavati from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Janssen Pharmaceuticals, Inc paid the most, $634.

Anish Nanavati graduated from Northeastern Ohio University College of Medicine in 2008.